查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1844102

血栓移除器械市场（按器械类型、最终用户和应用划分）—2025-2032年全球预测

Blood Clot Retrieval Devices Market by Device Type, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，血栓移除装置市场规模将达到 60.6 亿美元，复合年增长率为 14.78%。

主要市场统计数据
基准年 2024 20.1亿美元
预计年份：2025年 23亿美元
预测年份：2032年 60.6亿美元
复合年增长率 (%) 14.78%

简要介绍影响血栓移除装置和手术流程的技术、临床和监管因素

血栓移除装置已从最初的简易机械器械发展成为高度工程化的血管内系统，能够在危及生命的血栓事件中快速恢復灌注。过去十年，装置创新主要集中在提高其在迂曲血管内的操控性、提升血栓捕获和取出效率以及最大限度减少血栓移除中的远端栓塞。影像导引和导管技术的同步进步，共同创造了一个协同发展的环境，使得装置设计、手术技术和临床方案得以同步演进。

临床实务越来越注重时间敏感型介入治疗，因为器械性能直接影响神经系统和心肺功能的预后。因此，由介入神经科、血管外科医生和介入放射科医生组成的多学科团队正日益规范手术流程，以优化从入院到再灌注的时间。同时，製造商也不断改进产品，研发新的架构，优先考虑可追踪性、径向力控制和吸力相容性，以适应更广泛的血栓成分和解剖结构变异。

监管互动和证据蒐集也日趋成熟。如今，器械核准通常需要可靠的手术数据、已建立的手术比较以及上市后监测。因此，器械研发的策略规划必须包含临床试验设计、卫生经济学模型以及早期相关人员参与，以支持医院采纳和与支付方的互动。总而言之，临床疗效、手术效率和供应链韧性这三者将共同塑造该领域的竞争格局。

技术进步、临床路径改革和商业模式的演变，正从根本上改变血栓移除器材的格局。

血栓移除器械领域正经历显着的变革，这主要受技术进步、临床通讯协定的演变以及人们对治疗效果和成本预期转变的推动。在器械层面，製造商正在推出混合结构，将机械支架样元件与吸力相容的管腔结合。这些混合设计旨在提高首次通过率，同时降低手术复杂性。同时，影像和导航平台使得器械能够在远端和迂曲的解剖结构中实现更精准的部署，从而扩大了可治疗病变的范围，并促使人们重新评估介入治疗的适应症。

在临床上，随着中风诊疗体系和血管疾病诊疗计画优先考虑快速分诊、院前通知和简化院内工作流程，诊疗路径正变得日益整合。这种运作重点促使人们采用能够缩短手术时间和减少手术变异性的器械，从而提高首次手术成功率等指标并最大限度地减少器械更换。同时，跨领域培训和基于模拟的资格认证正在减少操作者差异，这反过来又影响采购决策和供应商支援模式。

从策略角度来看，这些转变正迫使供应商重新思考其商业模式。医疗服务提供者越来越重视包含培训、即时流程支援和数据分析（用于监测治疗效果）在内的捆绑式服务。同时，对全球供应链的考虑以及製造地多元化的需求，正在推动伙伴关係和本地化生产策略的建立。这些变化并非渐进式的，而是重新定义了临床表现、服务模式和竞争差异化的预期。

分析2025年美国关税对医疗设备采购、定价策略和供应链韧性的多面向营运和商业影响

2025年关税和贸易措施的实施，为依赖全球采购零件和成品设备的製造商、经销商和医疗保健系统带来了新的挑战。关税带来的成本压力将波及价值链的多个环节，包括原料采购、契约製造和跨境分销。不断上涨的成本迫使製造商重新审视供应商选择标准，考虑替代材料和零件，并尽可能加快关键製造流程的本地化进程。因此，近岸外包和产能多元化策略正从紧急计画转向主动的供应链重组。

除了直接的成本影响外，关税还会影响与医疗服务提供者和支付方的价格谈判，尤其是在报销率受限的地区。医院和门诊手术中心可能面临采购预算紧张的问题，因此他们优先选择手术效率高、辅助服务需求低的设备。为了缓解利润压缩，供应商正在寻求附加价值服务、延长保固期和基本契约，以维持商业性生存能力。

监管和海关合规负担也随之加重，需要更完善的文件、更长的前置作业时间和更大的库存缓衝，以避免流程中断。这些营运调整也会影响临床安排和融资时间表。因此，具有前瞻性的公司正在将情境规划与对供应商环节的深入了解相结合，以在持续的贸易摩擦面前，维持医疗保健的连续性、控製成本波动并保证产品供应。

利用与设备架构、临床环境和特定适应症的手术需求相关的可操作细分讯息，为开发和采购提供资讯。

细分市场分析揭示了产品开发、临床应用和筹资策略如何因器材类型、医疗环境和临床适应症而异。就器械类型而言，抽吸导管的操作特点在于直接抽吸，通常用于预期会形成柔软易碎血栓的病例。血栓摘取支架则提供机械嚙合和径向支撑，适用于组织型血栓。整合了抽吸和取栓机制的组合系统旨在捕捉更广泛的血栓形态，同时优化首次通过率，无论采用顺序部署还是同时部署。这种差异化影响研发优先顺序、临床训练需求以及手术中心的库存策略。

就最终用户而言，门诊手术中心、综合医院和血管专科诊所的采购理由和营运限制各不相同。门诊中心优先考虑的是吞吐量和单次就诊成本，而医院则通常需要在心臟和神经血管计画的急诊准备和资本规划之间取得平衡。在医院内部，心臟专科医院和神经血管专科中心各自製定能力矩阵，使设备组合与关键手术量和医生专业水平相匹配。这些机构差异会影响供应商的合作方式，包括支援方案、培训方法和首选合约结构。

临床应用进一步细化了器械选择和手术方案製定。深层静脉栓塞症形成，无论远端或近端，都需要能够维护静脉完整性并最大限度减少血栓后遗症的器械和手术方案。缺血性中风的治疗需要针对脑血管脆弱性和快速再灌注进行最佳化的器械，适用于急性缺血到亚急性及慢性阻塞的情况。肺动脉栓塞的治疗需要能够在维持血流动力学稳定的同时清除大量血栓的系统。由于每种适应症都需要独特的临床表现，因此，分段式的开发和商业化策略对于使产品系列与实际手术情况相符至关重要。

区域医疗基础设施、监管多样性和能力建设优先事项如何驱动差异化的招聘模式和打入市场策略

区域动态以多种方式塑造临床实践模式、监管管道和供应链设计，对医疗设备的采用和供应商策略产生重大影响。在美洲，密集的专科医疗中心和综合中风系统网络正在加速流程标准化，许多医疗机构都在投资建设中风基础设施和多学科中风团队。这种环境有利于那些展现出明显流程优势和可衡量的工作流程效率提升的医疗器材的快速普及，同时也有利于那些提供全面培训和上市后结果分析的供应商。

欧洲、中东和非洲的监管环境和医院能力各不相同，因此量身定制的市场准入参与策略和临床证据至关重要。欧洲核心市场的医疗服务提供者通常重视临床数据对比和卫生技术评估，而新兴市场的医疗服务提供者则可能更注重成本效益和供应可靠性。因此，製造商通常会采取差异化的市场准入策略，将监管市场中强有力的临床文件与针对不同医疗环境的有针对性的能力建设倡议和灵活的商业模式相结合。

快速的都市化、不断扩展的三级医疗网络以及对介入培训的投入，正推动亚太地区手术量的成长。这种成长使得可扩展的解决方案变得特别重要，这些解决方案既能满足大型医疗机构的需求，又能兼顾当地医院的便利性。监管协调的推进以及对本地製造业投资的增加，也在重塑竞争格局，促使跨国供应商考虑建立区域伙伴关係和生产基地，以加快市场准入并实现可持续的业务运营。

竞争与合作策略着重于临床差异化、服务整合与生命週期组合管理，以确保长期应用。

血栓移除器械领域的竞争格局呈现出多元化的态势，既有成熟的平台型参与企业，也有创新型挑战者，还有利用自身手术资源和服务生态系统来提升产品普及率的垂直整合型医疗设备公司。大型製造商和新兴参与企业都致力于透过展示手术优势来实现临床差异化，例如提高首次手术成功率、减少器械更换次数以及简化操作流程。为了实现这些目标，各公司都在投资于器械的迭代优化、支持辅助手术的模组化系统以及旨在缩短学习曲线并强化最佳实践的综合性临床医生教育计画。

此外，对于那些希望加快产品上市速度、拓展产品系列，同时又不想承担全部内部研发成本的公司而言，策略伙伴关係和授权协议正变得越来越普遍。此类合作模式涵盖分销协议、临床研究联盟以及共用生产能力等。那些将设备创新与强大的服务产品（例如术中支援、模拟培训和数据分析）相结合的供应商，往往能够与大批量生产中心和专业专案建立更紧密的合作关係。

最后，公司的策略整合了生命週期管理计划，该计划涵盖了设备的逐步改进、跨产品相容性以及对上市后监测的承诺。这种长期的产品组合管理方法有助于公司满足监管要求，同时保持临床相关性，并协助医院采购委员会优先考虑具有显着长期价值的产品。

为製造商和医疗保健系统提供具体可行的建议，以协调临床证据、培训、供应链弹性以及以金额为准的商业模式。

在流程规范日益严格、供应链日益复杂的环境下，产业领导者可以采取实际措施，协调商业性、临床和营运目标。首先，在产品开发早期阶段就整合临床证据生成，可确保医疗设备符合实际操作需求和监管要求，同时提供采购委员会所需的比较结果。透过让临床试验设计与目标最终用户相匹配，企业可以产生与心臟病医院、神经血管中心和高流量门诊机构等直接相关的证据。

其次，投资全面的培训和流程支援计画可以减少操作人员的差异，并加强供应商与医疗机构之间的联繫。基于模拟的资格认证、按需流程指导和结构化的术后总结汇报有助于将新设备整合到临床工作流程中，并提高首次通过率。第三，为了缓解关税相关的成本压力和物流中断，应优先考虑供应链的韧性，具体措施包括多元化采购、策略性库存布局以及潜在的区域製造伙伴关係关係。使采购计画与医院的资本週期保持一致，并提高供应商节点的透明度，可以进一步减少营运摩擦。

最后，商业模式应不断发展，纳入以结果为导向的合约、配套服务以及灵活的定价结构，从而体现流程效率和降低併发症发生率的价值。这种方法有助于医院在价格敏感的环境下证明采用这些服务的合理性，同时保障供应商的利润。透过结合实证实践、培训、稳健的供应链和适应性强的商业策略，企业领导者可以优化其产品组合，以实现永续应用并获得竞争优势。

透明的、三角验证的调查方法，结合了临床医生的第一手见解、程序资料检验和监管管道分析，确保得出可操作的结论。

本报告的调查方法采用了一种三角测量法，整合了主要相关人员访谈、流程资料分析以及监管和临床文献综述。主要资料来源包括对介入临床医生、医院采购负责人和器械工程师的结构化访谈，旨在了解他们对器械性能、工作流程影响和采购决策因素的本地化观点。这些定性见解与手术结果资料集和同行评审的临床研究进行了交叉比对，以检验性能声明并识别器械选择和临床决策中的模式。

同时，我们分析了监管申报文件和指导文件，以梳理主要司法管辖区的核准管道、上市后监管预期和标籤限制。供应链评估包括供应商网路分析、组件采购分析以及与製造外包製造商的沟通，以识别生产瓶颈和供应多元化的机会。整合这些讯息，我们得以全面了解医疗器材的生命週期考量，涵盖从设计到临床应用、商业化和上市后支援的各个阶段。

在整个过程中，我们始终专注于确保所有解读均基于当前的临床实践和监管实际情况。我们采用了过渡性检查和反覆的专家同行评审，以保持对不断发展的程序标准的遵循，并确保研究结果对生产、临床运营和采购决策者俱有实际指导意义。

策略性结论重点阐述了临床表现、证据产生和供应韧性如何共同决定血栓移除技术的长期应用。

总之，血栓移除领域融合了精密的器材工程、高风险的临床决策和复杂的商业性动态。器械架构和影像引导技术的创新不断拓展手术的可能性，而临床工作流程和资格认证的变革则提高了器械性能和手术效率的标准。关税带来的供应链压力和区域监管差异进一步凸显了建立具有韧性的製造地和差异化打入市场策略的必要性。

为了因应这种环境，相关人员必须使产品开发与不同终端使用者的实际需求保持一致，产生可靠的临床证据以证明手术效果，并实施灵活的商业模式，充分考虑医院和专科诊所的运作实际情况。这样做不仅能帮助製造商和医疗系统应对短期挑战，还能让他们从长期转向更整合、以结果为导向的医疗模式转变中获益。最终，能否提供具有临床意义的益处，并辅以可重复的证据和可靠的供应，将决定哪些解决方案能够获得广泛且持续的应用。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 抽吸血栓切除术合併支架取栓装置的应用日益增多，以提高血管再通率
  • 开发具有更高柔韧性和在迂曲血管中导航能力的新一代导管设计
  • 机械取栓术与动脉内溶栓术结合在急性中风通讯协定中变得越来越重要。
  • 将血栓切除装置与即时影像支援相结合，以优化血栓切除术的准确性
  • 缺血性中风发病率的上升推动了对快速血栓清除解决方案的需求。
  • 生物相容性涂层技术的进步可减少取栓装置的血栓形成
  • 人工智慧导引装置定位系统的出现，提高了血栓切除手术的手术效率
  • 将血栓切除装置的适应症从神经血管应用扩展到週边动脉和静脉应用

第六章美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

第八章 按器械类型血栓移除器械市场

  • 吸管
  • 复杂系统
    • 连续收集机
    • 同时收集机
  • 支架取出机

第九章 依最终用户血栓移除器械市场

  • 门诊手术中心
  • 医院
    • 心臟医院
    • 神经血管中心
  • 血管专科诊所

第十章 按应用分類的血栓移除器械市场

  • 深层静脉栓塞症
    • 远端深层静脉栓塞症
    • 近端深层静脉栓塞症
  • 缺血性中风
    • 急性缺血性脑中风
    • 亚急性及慢性阻塞
  • 肺动脉栓塞
    • 严重肺动脉栓塞
    • 亚大块肺动脉栓塞

第十一章血栓移除器械市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十二章血栓移除器械市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十三章 各国血栓移除器材市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十四章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Medtronic plc
    • Stryker Corporation
    • Penumbra, Inc.
    • Boston Scientific Corporation
    • MicroPort Scientific Corporation
    • Terumo Corporation
    • Johnson & Johnson
    • Integra LifeSciences Holdings Corporation
    • Cardinal Health, Inc.
    • AngioDynamics, Inc.
Product Code: MRR-A26E0E574192

The Blood Clot Retrieval Devices Market is projected to grow by USD 6.06 billion at a CAGR of 14.78% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.01 billion
Estimated Year [2025] USD 2.30 billion
Forecast Year [2032] USD 6.06 billion
CAGR (%) 14.78%

A concise introduction to the technological, clinical, and regulatory forces reshaping blood clot retrieval devices and procedural pathways

Blood clot retrieval devices have advanced from rudimentary mechanical implements to highly engineered endovascular systems capable of rapidly restoring perfusion in life-threatening thrombotic events. Over the past decade, device innovation has concentrated on improving navigability within tortuous vasculature, enhancing clot engagement and extraction efficiency, and minimizing distal embolization during retrieval. Concurrent advancements in imaging guidance and catheter technology have created a synergistic environment in which device design, procedural techniques, and clinical protocols evolve in concert.

In clinical settings, the emphasis has shifted toward time-sensitive interventions where device performance directly affects neurological and cardiopulmonary outcomes. As a result, multidisciplinary teams that integrate interventional neurologists, vascular surgeons, and interventional radiologists are increasingly standardizing procedural pathways to optimize door-to-reperfusion times. Meanwhile, manufacturers are pursuing iterative improvements and novel architectures that prioritize trackability, radial force control, and aspiration compatibility to accommodate a wider range of clot compositions and anatomical variations.

Regulatory engagement and evidence generation have also matured. Device approvals now commonly require robust procedural data, comparative metrics against established techniques, and post-market surveillance commitments. Consequently, strategic planning for device development must encompass clinical trial design, health economic modeling, and early stakeholder engagement to support hospital adoption and payer dialogue. Taken together, these forces frame an environment where clinical efficacy, procedural efficiency, and supply chain resilience all shape the competitive contours of the sector.

How convergent technological advances, clinical pathway reforms, and evolving commercial models are fundamentally transforming the blood clot retrieval device landscape

The landscape for clot retrieval devices is undergoing transformative shifts driven by converging technological advances, evolving clinical protocols, and changing ecosystem expectations around outcomes and cost. At the device level, manufacturers are introducing hybrid architectures that combine mechanical stent-like elements with aspiration-compatible lumens, and those hybrid designs aim to improve first-pass efficacy while reducing procedural complexity. Simultaneously, imaging and navigation platforms have enabled more precise device deployment in distal and tortuous anatomy, expanding the range of treatable lesions and prompting re-evaluation of inclusion criteria for intervention.

Clinically, care pathways are becoming more integrated as stroke systems of care and vascular programs prioritize rapid triage, pre-hospital notification, and streamlined in-hospital workflows. This operational emphasis has incentivized devices that reduce procedure time and variability, and it has elevated metrics such as first-pass success and minimized device exchanges. In parallel, cross-disciplinary training and simulation-based credentialing are reducing operator-dependent variability, which in turn influences purchasing decisions and vendor support models.

From a strategic standpoint, these shifts are prompting suppliers to rethink commercial models. Providers increasingly value bundled offerings that include training, real-time procedural support, and data analytics to monitor outcomes. At the same time, global supply chain considerations and the desire for diversified manufacturing footprints are encouraging partnerships and regionalized production strategies. Together, these changes are not incremental; they are redefining expectations across clinical performance, service models, and competitive differentiation.

Analyzing the multifaceted operational and commercial repercussions of United States tariffs in 2025 on device sourcing, pricing strategies, and supply chain resilience

The imposition of tariffs and trade measures in 2025 has introduced new layers of complexity for manufacturers, distributors, and health systems that rely on globally sourced components and finished devices. Tariff-induced cost pressures manifest across multiple nodes of the value chain, including raw-material procurement, contract manufacturing, and cross-border distribution. These increased costs compel manufacturers to re-evaluate supplier selection criteria, explore alternative materials or components, and accelerate initiatives to localize critical manufacturing steps where feasible. As a consequence, nearshoring and capacity diversification strategies have moved from contingency planning to active supply chain redesign.

In addition to direct cost implications, tariffs influence pricing negotiations with healthcare providers and payers, particularly in regions where reimbursement rates are constrained. Hospitals and ambulatory surgical centers may face tighter procurement budgets and therefore prioritize devices that demonstrate robust procedural efficiency and lower ancillary service requirements. To mitigate margin compression, suppliers are pursuing value-added services, extended warranties, and outcome-based contracting to preserve commercial viability.

Regulatory and customs compliance burdens have also increased, requiring enhanced documentation, longer lead times, and greater inventory buffers to avoid procedural disruptions. These operational adaptations have ripple effects on clinical scheduling and capital procurement timelines. Therefore, forward-looking organizations are combining scenario planning with more granular visibility into supplier nodes to maintain continuity of care, manage cost volatility, and sustain product availability in the face of persistent trade friction.

Actionable segmentation intelligence linking device architectures, clinical settings, and indication-specific procedural demands to inform development and procurement

Insight into segmentation reveals how product development, clinical adoption, and procurement strategies diverge across device typologies, care settings, and clinical indications. When device type is considered, aspiration catheters offer a procedural profile centered on direct suction and are frequently selected for cases where soft, friable thrombus is anticipated; stent retrievers provide mechanical engagement and radial support suitable for organized clots; and combined systems that integrate aspiration with retriever mechanics-whether deployed sequentially or simultaneously-aim to capture a broader spectrum of thrombus morphologies while optimizing first-pass efficacy. This differentiation impacts R&D prioritization, clinical training requirements, and inventory strategies at procedural centers.

Regarding end users, ambulatory surgical centers, general hospitals, and specialized vascular clinics present distinct purchasing rationales and operational constraints. Ambulatory centers emphasize throughput and cost per episode, whereas hospitals often balance acute care readiness with capital planning across cardiac and neurovascular programs. Within hospitals, cardiac hospitals and dedicated neurovascular centers develop unique competency matrices and device formularies aligned with their dominant procedural volumes and specialist expertise. These institutional distinctions shape vendor engagement approaches, including support packages, training modalities, and preferred contract structures.

Clinical application further stratifies device selection and procedural planning. Deep vein thrombosis cases, whether distal or proximal, demand devices and techniques that preserve venous integrity and minimize post-thrombotic sequelae. Ischemic stroke interventions, spanning acute ischemic presentations and subacute or chronic occlusions, require devices optimized for cerebral vessel fragility and rapid reperfusion. Pulmonary embolism treatment, across massive and submassive presentations, necessitates systems capable of extracting large clot burdens while maintaining hemodynamic stability. Each indication imposes discrete clinical performance requirements, and therefore segmentation-aware development and commercialization strategies are essential for aligning product portfolios with procedural realities.

How regional healthcare infrastructure, regulatory diversity, and capacity-building priorities drive differentiated adoption patterns and market entry strategies

Regional dynamics shape clinical practice patterns, regulatory pathways, and supply chain design in ways that materially affect device adoption and vendor strategy. In the Americas, a dense network of tertiary centers and integrated stroke systems has accelerated procedural standardization, with many institutions investing in stroke-ready infrastructure and multidisciplinary stroke teams. This environment supports rapid adoption of devices that demonstrate clear procedural advantages and measurable improvements in workflow efficiency, and it also favors vendors that offer comprehensive training and post-market outcome analytics.

In Europe, the Middle East & Africa region, heterogeneous regulatory landscapes and variable hospital capabilities create a market where tailored entry strategies and localized clinical evidence are paramount. Providers in core European markets often emphasize comparative clinical data and health technology assessments, whereas centers in emerging markets may prioritize cost-effectiveness and supply reliability. Consequently, manufacturers often pursue differentiated market access approaches, combining robust clinical dossiers in regulated markets with targeted capacity-building initiatives and flexible commercial models in varied healthcare settings.

In the Asia-Pacific region, rapid urbanization, expanding tertiary care networks, and investments in interventional training are driving procedural volumes upward. This growth is accompanied by an emphasis on scalable solutions that cater to high-volume centers while remaining accessible to regional hospitals. Regulatory harmonization efforts and increasing local manufacturing investments are also shaping the competitive environment, prompting multinational suppliers to consider regional partnerships and production footprints to support faster market entry and sustainable operations.

Competitive and collaborative company strategies focused on clinical differentiation, service integration, and lifecycle portfolio management to secure durable adoption

Competitive dynamics in the clot retrieval device space reflect a blend of entrenched platform players, innovative challengers, and vertically integrated medical device companies that leverage surgical capital and service ecosystems to strengthen adoption. Leading manufacturers and emerging entrants alike focus on clinical differentiation through demonstrable procedural benefits such as increased first-pass success, reduced device exchanges, and simplified operator workflows. To achieve these outcomes, companies are investing in iterative device optimization, modular systems that support complementary procedural techniques, and comprehensive clinician education programs that shorten learning curves and reinforce best practices.

Moreover, strategic partnerships and licensing arrangements are increasingly prevalent as firms seek to accelerate time-to-market and broaden product portfolios without incurring the full cost of in-house development. These collaborative models extend to distribution agreements, clinical research consortia, and shared manufacturing capacity. Vendors that pair device innovation with strong service offerings-such as intra-procedural support, simulation training, and data analytics-tend to establish stickier relationships with high-volume centers and specialty programs.

Finally, corporate strategies are integrating lifecycle management plans that consider incremental device improvements, compatibility across product families, and post-market surveillance commitments. This long-view approach to portfolio management helps firms navigate regulatory expectations while maintaining clinical relevance and supporting hospital procurement committees that prioritize demonstrable long-term value.

Concrete, implementable recommendations for manufacturers and health systems to align clinical evidence, training, supply resilience, and value-based commercial models

Industry leaders can take concrete steps to align commercial, clinical, and operational objectives in an environment of accelerating procedural expectations and supply chain complexity. First, integrating clinical evidence generation into product development from early stages will ensure that devices meet practical procedural needs and regulatory requirements, while also producing the comparative outcomes required by procurement committees. By coordinating clinical trial design with target end users, companies can generate evidence that is directly relevant to cardiac hospitals, neurovascular centers, and high-volume ambulatory facilities alike.

Second, investing in comprehensive training and procedural support programs reduces operator variability and strengthens vendor ties with institutions. Simulation-based credentialing, on-demand procedural coaching, and structured post-procedure debriefs help embed new devices into clinical workflows and enhance first-pass performance metrics. Third, supply chain resilience must be prioritized through diversified sourcing, strategic inventory positioning, and potential regional manufacturing partnerships to mitigate tariff-related cost pressures and logistics disruptions. Aligning procurement timelines with hospital capital cycles and enhancing visibility across supplier nodes will further reduce operational friction.

Finally, commercial models should evolve to include outcome-oriented contracting, bundled services, and flexible pricing structures that reflect the value of procedural efficiency and reduced complication rates. These approaches make it easier for hospitals to justify adoption while preserving vendor margins in price-sensitive environments. By combining evidence generation, training, supply chain robustness, and adaptive commercial strategies, leaders can position their portfolios for sustainable adoption and competitive resilience.

A transparent, triangulated research methodology combining primary clinician insights, procedural data validation, and regulatory pathway analysis to ensure actionable conclusions

The research underpinning this report applied a triangulated methodology that integrates primary stakeholder interviews, procedural data analysis, and regulatory and clinical literature review. Primary inputs included structured interviews with interventional clinicians, hospital procurement leaders, and device engineers to capture frontline perspectives on device performance, workflow impacts, and purchasing determinants. These qualitative insights were cross-referenced with procedural outcome datasets and peer-reviewed clinical studies to validate performance claims and to identify patterns in device selection and clinical decision-making.

In parallel, regulatory filings and guidance documents were analyzed to map approval pathways, post-market surveillance expectations, and labeling constraints across major jurisdictions. Supply chain assessments incorporated supplier network mapping, component sourcing analysis, and conversations with contract manufacturers to understand production bottlenecks and opportunities for supply diversification. The synthesis of these streams facilitated a comprehensive view of device lifecycle considerations, from design and clinical adoption to commercialization and post-market support.

Throughout, care was taken to ensure that interpretations remain grounded in current clinical practice and regulatory realities. Transitional checks and iterative peer reviews with subject-matter experts were employed to maintain fidelity to evolving procedural standards and to ensure the research outputs remain actionable for decision-makers in manufacturing, clinical operations, and procurement.

A strategic conclusion highlighting how clinical performance, evidence generation, and supply resilience converge to determine durable adoption of clot retrieval technologies

In conclusion, the blood clot retrieval space sits at the intersection of sophisticated device engineering, high-stakes clinical decision-making, and complex commercial dynamics. Innovation in device architecture and imaging guidance is expanding the boundaries of what is treatable, while changes in clinical workflows and credentialing are raising the bar for device performance and procedural efficiency. Tariff-driven supply chain stresses and regional regulatory heterogeneity further underscore the necessity for resilient manufacturing footprints and differentiated market-access strategies.

To navigate this environment, stakeholders must align product development with the real-world needs of diverse end users, generate robust clinical evidence that speaks to procedural outcomes, and implement flexible commercial models that recognize the operational realities of hospitals and specialty clinics. By doing so, manufacturers and health systems can not only manage near-term disruptions but also capitalize on longer-term shifts toward more integrated, outcome-focused care models. Ultimately, the ability to deliver clinically meaningful benefits, supported by reproducible evidence and reliable supply, will determine which solutions achieve broad and sustained adoption.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of aspiration thrombectomy combined with stent retrievers for improved recanalization rates
  • 5.2. Development of next generation catheter designs with enhanced flexibility and navigation in tortuous vessels
  • 5.3. Growing emphasis on combining mechanical thrombectomy with intra-arterial thrombolytic therapy in acute stroke protocols
  • 5.4. Integration of real-time imaging support with thrombectomy devices for optimized clot retrieval accuracy
  • 5.5. Increasing prevalence of ischemic stroke driving demand for rapid blood clot retrieval solutions
  • 5.6. Advancements in biocompatible coating technologies to reduce thrombogenicity of retrieval devices
  • 5.7. Emergence of AI-guided device positioning systems to augment procedural efficiency in thrombectomy procedures
  • 5.8. Expanding indications for thrombectomy devices in peripheral arterial and venous applications beyond neurovascular use

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Clot Retrieval Devices Market, by Device Type

  • 8.1. Aspiration Catheter
  • 8.2. Combined System
    • 8.2.1. Sequential Retrievers
    • 8.2.2. Simultaneous Retrievers
  • 8.3. Stent Retriever

9. Blood Clot Retrieval Devices Market, by End User

  • 9.1. Ambulatory Surgical Center
  • 9.2. Hospital
    • 9.2.1. Cardiac Hospital
    • 9.2.2. Neurovascular Center
  • 9.3. Specialized Vascular Clinic

10. Blood Clot Retrieval Devices Market, by Application

  • 10.1. Deep Vein Thrombosis
    • 10.1.1. Distal Deep Vein Thrombosis
    • 10.1.2. Proximal Deep Vein Thrombosis
  • 10.2. Ischemic Stroke
    • 10.2.1. Acute Ischemic Stroke
    • 10.2.2. Subacute And Chronic Occlusion
  • 10.3. Pulmonary Embolism
    • 10.3.1. Massive Pulmonary Embolism
    • 10.3.2. Submassive Pulmonary Embolism

11. Blood Clot Retrieval Devices Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Blood Clot Retrieval Devices Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Blood Clot Retrieval Devices Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. Medtronic plc
    • 14.3.2. Stryker Corporation
    • 14.3.3. Penumbra, Inc.
    • 14.3.4. Boston Scientific Corporation
    • 14.3.5. MicroPort Scientific Corporation
    • 14.3.6. Terumo Corporation
    • 14.3.7. Johnson & Johnson
    • 14.3.8. Integra LifeSciences Holdings Corporation
    • 14.3.9. Cardinal Health, Inc.
    • 14.3.10. AngioDynamics, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BLOOD CLOT RETRIEVAL DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. BLOOD CLOT RETRIEVAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BLOOD CLOT RETRIEVAL DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ASPIRATION CATHETER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ASPIRATION CATHETER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ASPIRATION CATHETER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ASPIRATION CATHETER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ASPIRATION CATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ASPIRATION CATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SEQUENTIAL RETRIEVERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SEQUENTIAL RETRIEVERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SEQUENTIAL RETRIEVERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SEQUENTIAL RETRIEVERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SEQUENTIAL RETRIEVERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SEQUENTIAL RETRIEVERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SIMULTANEOUS RETRIEVERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SIMULTANEOUS RETRIEVERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SIMULTANEOUS RETRIEVERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SIMULTANEOUS RETRIEVERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SIMULTANEOUS RETRIEVERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SIMULTANEOUS RETRIEVERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY STENT RETRIEVER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY STENT RETRIEVER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY STENT RETRIEVER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY STENT RETRIEVER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY STENT RETRIEVER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY STENT RETRIEVER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY CARDIAC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY CARDIAC HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY CARDIAC HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY CARDIAC HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY CARDIAC HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY CARDIAC HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY NEUROVASCULAR CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY NEUROVASCULAR CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY NEUROVASCULAR CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY NEUROVASCULAR CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY NEUROVASCULAR CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY NEUROVASCULAR CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SPECIALIZED VASCULAR CLINIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SPECIALIZED VASCULAR CLINIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SPECIALIZED VASCULAR CLINIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SPECIALIZED VASCULAR CLINIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SPECIALIZED VASCULAR CLINIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SPECIALIZED VASCULAR CLINIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DISTAL DEEP VEIN THROMBOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DISTAL DEEP VEIN THROMBOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DISTAL DEEP VEIN THROMBOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DISTAL DEEP VEIN THROMBOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DISTAL DEEP VEIN THROMBOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DISTAL DEEP VEIN THROMBOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PROXIMAL DEEP VEIN THROMBOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PROXIMAL DEEP VEIN THROMBOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PROXIMAL DEEP VEIN THROMBOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PROXIMAL DEEP VEIN THROMBOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PROXIMAL DEEP VEIN THROMBOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PROXIMAL DEEP VEIN THROMBOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ACUTE ISCHEMIC STROKE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ACUTE ISCHEMIC STROKE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ACUTE ISCHEMIC STROKE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ACUTE ISCHEMIC STROKE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ACUTE ISCHEMIC STROKE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ACUTE ISCHEMIC STROKE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBACUTE AND CHRONIC OCCLUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBACUTE AND CHRONIC OCCLUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBACUTE AND CHRONIC OCCLUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBACUTE AND CHRONIC OCCLUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBACUTE AND CHRONIC OCCLUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBACUTE AND CHRONIC OCCLUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY MASSIVE PULMONARY EMBOLISM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY MASSIVE PULMONARY EMBOLISM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY MASSIVE PULMONARY EMBOLISM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY MASSIVE PULMONARY EMBOLISM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY MASSIVE PULMONARY EMBOLISM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY MASSIVE PULMONARY EMBOLISM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBMASSIVE PULMONARY EMBOLISM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBMASSIVE PULMONARY EMBOLISM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBMASSIVE PULMONARY EMBOLISM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBMASSIVE PULMONARY EMBOLISM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBMASSIVE PULMONARY EMBOLISM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBMASSIVE PULMONARY EMBOLISM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 162. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 168. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 178. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 182. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 184. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 190. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 232. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 236. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 245. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 250. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 251. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 252. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 253. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 254. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 288. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 289. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 292. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 293. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN BLOOD CLOT RETRIEVAL DEVIC